RSV – Page 2 – Global Health Press

GHP News Latest Science

The economic and clinical impact of RSV in older adults

Respiratory syncytial virus (RSV) poses a significant health risk to individuals aged 60 years and older, often leading to severe acute respiratory infections (ARIs) that result in hospitalizations and substantial...

3 March, 2025

4 min read

GHP News Latest Science

High levels of RSV cases highlight need for greater vaccine awareness

Respiratory syncytial virus (RSV) cases have reached alarming levels across the United States, with several states reporting “very high” activity according to CDC wastewater testing. This surge underscores...

10 January, 2025

4 min read

GHP News Latest Science

RSV vaccination in older adults with health conditions is cost-effective

Targeting vaccination programs for respiratory syncytial virus (RSV) to older adults with underlying health conditions is a cost-effective way to reduce disease, according to a new modelling study. RSV infections cause...

16 September, 2024

3 min read

GHP News Podcast Videos

Global Health Cast Edition 72

Seventy-second Edition of the Global Health Cast presented by Prof. Schmitt and Dr. Sanicas. Download the PDF here.🔒 Premium Content - For FreeUnlock this content by becoming a Global Health Press subscriber. Join for...

7 August, 2024

1 min read

Latest Science

Severe lung damage caused when flu is followed by infection with measles-like virus

Infection with a measles-like virus causes catastrophic lung failure in ferrets previously infected with influenza virus or respiratory syncytial virus, according to a study by researchers in the Center for...

9 February, 2024

3 min read

Latest Science

7 of the biggest medical breakthroughs in 2023

From new vaccines to the first drugs of their kind for hard-to-treat disorders, 2023 has been a year full of medical breakthroughs. They offer opportunities for people to protect themselves from diseases, slow down the...

2 January, 2024

9 min read

GHP News

Catch me if you can: how three infectious disease agents evade the immune system

NTU researchers are understanding how the respiratory syncytial virus, Chikungunya virus and malaria parasite escape being detected by the immune system. COVID-19 cast a glaring spotlight on the devastating impact that...

7 December, 2023

6 min read

Latest Science

Co-administration of RSV, influenza vaccines found safe and effective in new study

The co-administration of bivalent respiratory syncytial virus (RSV) prefusion F protein−based vaccine (RSVpreF) and seasonal influenza vaccine was found to generate robust immune responses and was safe and well...

6 December, 2023

3 min read

Latest Science

RSV-preventing injection in shortage as respiratory virus season begins

Respiratory virus season is only starting, and demand has already outstripped supply for the newly approved and potentially lifesaving monoclonal antibody injection for preventing respiratory syncytial virus (RSV) in...

20 November, 2023

5 min read

GHP News Podcast Videos

Global Health Cast Edition 51

Fifty-first Edition of the Global Health Cast presented by Prof. Schmitt and Dr. Sanicas. Download the PDF here🔒 Premium Content - For FreeUnlock this content by becoming a Global Health Press subscriber. Join for...

25 October, 2023

1 min read

Tag - RSV